EFFECT OF TOREMIFENE IN BREAST-CANCER PATIENTS - PRELIMINARY COMMUNICATION

被引：9
|
作者：
HINDY, I
JUHOS, E
SZANTO, J
SZAMEL, I
机构：
[1] National Institute of Oncology, 1525 Budapest
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90010-P
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Toremifene, an antiestrogenic drug administered at three dose levels (60, 120, and 300 mg/day) was investigated in 17 postmenopausal patients with advanced breast cancer previously treated with hormonal and/or cytostatic therapy. The drug proved to be well tolerated at all dose levels without any serious side effects even on prolonged administration. Neither response nor side effects have shown any dose dependency in this small group of patients. © 1990.
引用
收藏
页码：225 / 226
页数：2
相关论文
共 50 条
  • [21] CELL COMMUNICATION IN BREAST-CANCER
    FENTIMAN, IS
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1980, 62 (04) : 280 - 286
  • [22] RANDOMIZED STUDY OF PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS WITH 170 BREAST-CANCER PATIENTS
    DURAND, M
    MAURIAC, L
    PIGNEUX, J
    AVRIL, A
    DILHUYDY, JM
    MAREE, D
    BULLETIN DU CANCER, 1988, 75 (07) : 656 - &
  • [23] Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients
    Bertelli, G
    Queirolo, P
    Vecchio, S
    Angiolini, C
    Bergaglio, M
    Del Mastro, L
    Signorini, A
    Valenzano, M
    Venturini, M
    ANTICANCER RESEARCH, 2000, 20 (5C) : 3659 - 3661
  • [24] PRELIMINARY TRIAL OF AMINOGLUTETHIMIDE IN BREAST-CANCER
    GRIFFITHS, CT
    HALL, TC
    SABA, Z
    BARLOW, JJ
    NEVINNY, HB
    CANCER, 1973, 32 (01) : 31 - 37
  • [25] RISK OF BREAST-CANCER TO RELATIVES OF YOUNG BREAST-CANCER PATIENTS
    SCHWARTZ, AG
    KING, MC
    BELLE, SH
    SATARIANO, WA
    SWANSON, GM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1985, 75 (04): : 665 - 668
  • [26] MULTICENTER PHASE-II EFFICACY TRIAL OF TOREMIFENE IN TAMOXIFEN-REFRACTORY PATIENTS WITH ADVANCED BREAST-CANCER
    VOGEL, CL
    SHEMANO, I
    SCHOENFELDER, J
    GAMS, RA
    GREEN, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) : 345 - 350
  • [27] PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER
    MODIG, H
    BORGSTROM, S
    NILSSON, I
    WESTMAN, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 237 - 238
  • [28] BREAST-CANCER RISKS IN RELATIVES OF MALE BREAST-CANCER PATIENTS
    ANDERSON, DE
    BADZIOCH, MD
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (14) : 1114 - 1117
  • [29] Toremifene in the treatment of breast cancer
    Mustonen, Mika V. J.
    Pyrhonen, Seppo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (03): : 393 - 405
  • [30] CARDIOTOXIC EFFECT OF CYTOSTATIC DRUGS IN BREAST-CANCER PATIENTS
    NEKLYUDOVA, VI
    SEREGUIN, GI
    SHKHVATSABAYA, LV
    VOPROSY ONKOLOGII, 1985, 31 (09) : 50 - 57
12345